(Q40470611)

20 September 2017

title

Urotensin II stimulates plasma extravasation in mice via UT receptor activation. (English)

1 reference

20 September 2017

5

1 reference

20 September 2017

Severo Salvadori

7

0 references

Domenico Regoli

8

object named as

Domenico Regoli

1 reference

20 September 2017

Raffaella Vergura

1

1 reference

20 September 2017

Valeria Camarda

2

1 reference

20 September 2017

Anna Rizzi

3

1 reference

20 September 2017

Martina Spagnol

4

1 reference

20 September 2017

Girolamo Calo'

6

1 reference

20 September 2017

publication date

23 October 2004

1 reference

Naunyn-Schmiedeberg's Archives of Pharmacology

20 September 2017

published in

1 reference

20 September 2017

volume

370

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

347-352

1 reference

Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-004-0991-9

Complex effects of Gillichthys urotensin II on rat aortic strips

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00210-004-0991-9

Contraction of major artery segments of rat by fish neuropeptide urotensin II

21 January 2018

1 reference

12 December 2020

Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas.

1 reference

12 December 2020

High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man

1 reference

12 December 2020

The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma

1 reference

12 December 2020

Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

1 reference

12 December 2020

Urotensin II evokes potent vasoconstriction in humans in vivo

1 reference

12 December 2020

Congestive heart failure and expression of myocardial urotensin II.

1 reference

12 December 2020

Structure-activity relationship study on human urotensin II

1 reference

12 December 2020

Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes

1 reference

12 December 2020

Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey

1 reference

12 December 2020

Cardiovascular actions of human urotensin II--considerations for hypertension

1 reference

12 December 2020

From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function

1 reference

12 December 2020

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

1 reference

12 December 2020

Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents

1 reference

12 December 2020

Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators

1 reference

12 December 2020

Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

1 reference

12 December 2020

Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues

1 reference

12 December 2020

Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries

1 reference

12 December 2020

Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats

1 reference

12 December 2020

Effect of human urotensin-II infusion on hemodynamics and cardiac function

1 reference

12 December 2020

Urotensin-II: a novel systemic hypertensive factor in the cat

1 reference

12 December 2020

Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy

1 reference

12 December 2020

Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension

1 reference

12 December 2020

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

12 December 2020

Neurogenic plasma leakage in mouse airways

1 reference

12 December 2020

Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14

1 reference

12 December 2020

Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats

1 reference

12 December 2020

Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries

1 reference

12 December 2020

Role of urotensin II in patients on dialysis

1 reference

12 December 2020

A new ligand for the urotensin II receptor

1 reference

12 December 2020

Central effects of urotensin-II following ICV administration in rats

1 reference

12 December 2020

Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes

1 reference

12 December 2020

Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta

1 reference

12 December 2020

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

1 reference

12 December 2020

Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats

1 reference

12 December 2020

Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure

1 reference

12 December 2020

Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

1 reference

12 December 2020

International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology

1 reference

12 December 2020

Increased plasma urotensin II levels in patients with diabetes mellitus

1 reference

12 December 2020

10.1007/S00210-004-0991-9

Identifiers

DOI

1 reference

20 September 2017

1 reference